| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Departments of Pathology and Laboratory Medicine [H. Z., J. I. D.] and Biochemistry and Molecular Biology [A. T. S., D. D. E., G. B.], College of Medicine, and Immunology Program [S. W., J. Y. D., G. B.], H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, Florida 33612, and Department of Internal Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104 [G. D. W.]
Tumor cell lines with a defective retinoblastoma gene are unable to transcribe the HLA class II genes in response to IFN-
treatment, and reconstitution of functional Rb rescues IFN-
-induced class II gene expression. However, the molecular mechanism of Rb rescue of the class II genes is unknown. We have examined the effect of Rb expression on the activation of the promoter for HLA-DRA, the prototype class II gene. Oct-1, a POU domain transcription factor, was identified as a repressor of HLA-DRA promoter activity in the Rb-defective cells. Rb expression led to phosphorylation of Oct-1, thus relieving its repressive effect. Oct-1 has also been shown to repress interleukin 8 promoter activity. Consistent with reduced levels of Oct-1 DNA binding activity in the Rb-transformed cell lines, interleukin 8 expression is higher in these cell lines.
This article has been cited by other articles:
![]() |
A. S. Sirek, L. Liu, M. Naples, K. Adeli, D. S. Ng, and T. Jin Insulin Stimulates the Expression of Carbohydrate Response Element Binding Protein (ChREBP) by Attenuating the Repressive Effect of Pit-1, Oct-1/Oct-2, and Unc-86 Homeodomain Protein Octamer Transcription Factor-1 Endocrinology, August 1, 2009; 150(8): 3483 - 3492. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Niesen, A. R. Osborne, W. R. Lagor, H. Zhang, K. Kazemfar, G. C. Ness, and G. Blanck Technological advances in the study of HLA-DRA promoter regulation: Extending the functions of CIITA, Oct-1, Rb, and RFX Acta Biochim Biophys Sin, March 1, 2009; 41(3): 198 - 205. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Niesen, A. R. Osborne, H. Yang, S. Rastogi, S. Chellappan, J. Q. Cheng, J. M. Boss, and G. Blanck Activation of a Methylated Promoter Mediated by a Sequence-specific DNA-binding Protein, RFX J. Biol. Chem., November 25, 2005; 280(47): 38914 - 38922. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Mesplede, M.-L. Island, N. Christeff, F. Petek, J. Doly, and S. Navarro The POU Transcription Factor Oct-1 Represses Virus-Induced Interferon A Gene Expression Mol. Cell. Biol., October 1, 2005; 25(19): 8717 - 8731. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Osborne, H. Zhang, G. Fejer, K. M. Palubin, M. I. Niesen, and G. Blanck Oct-1 Maintains an Intermediate, Stable State of HLA-DRA Promoter Repression in Rb-defective Cells: AN Oct-1-CONTAINING REPRESSOSOME THAT PREVENTS NF-Y BINDING TO THE HLA-DRA PROMOTER J. Biol. Chem., July 9, 2004; 279(28): 28911 - 28919. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Gordon, S. Saleque, and B. K. Birshtein Yin Yang 1 Is a Lipopolysaccharide-Inducible Activator of the Murine 3' Igh Enhancer, hs3 J. Immunol., June 1, 2003; 170(11): 5549 - 5557. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Osborne, H. Zhang, W.-M. Yang, E. Seto, and G. Blanck Histone Deacetylase Activity Represses Gamma Interferon-Inducible HLA-DR Gene Expression following the Establishment of a DNase I-Hypersensitive Chromatin Conformation Mol. Cell. Biol., October 1, 2001; 21(19): 6495 - 6506. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ameixa and J. S. Friedland Down-Regulation of Interleukin-8 Secretion from Mycobacterium tuberculosis-Infected Monocytes by Interleukin-4 and -10 but Not by Interleukin-13 Infect. Immun., April 1, 2001; 69(4): 2470 - 2476. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Eason and G. Blanck High Level Class II trans-Activator Induction Does Not Occur with Transient Activation of the IFN-{{gamma}} Signaling Pathway J. Immunol., January 15, 2001; 166(2): 1041 - 1048. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhang, S. Wei, J. Sun, D. Coppola, B. Zhong, G. D. Wu, B. Goodwin, S. Sebti, J. Y. Djeu, and G. Blanck Retinoblastoma Protein Activation of Interleukin 8 Expression Inhibits Tumor Cell Survival in Nude Mice Cell Growth Differ., December 1, 2000; 11(12): 635 - 639. [Abstract] [Full Text] |
||||
![]() |
T. Jin and H. Li POU Homeodomain Protein OCT1 Is Implicated in the Expression of the Caudal-related Homeobox Gene Cdx-2 J. Biol. Chem., April 27, 2001; 276(18): 14752 - 14758. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |